European Pharmaceutical Review

JULY 21, 2023

Recommendations were also published earlier this year for all stakeholders in the pharma supply chain. In this Q&A EPR speaks to Naser Al Yammahi the Deputy CEO of Hayat Biotech about pharmaceutical supply chain challenges and how they can be addressed. Globalisation and supply chain complexity are a factor.

Pharmaceutical 92

Pharmaceutical Food and Drug Administration Transportation Manufacturing 92

European Pharmaceutical Review

JULY 25, 2022

.” These products are disguised as legitimate branded medicines and it can be difficult for those across the supply chain, as well as patients, to detect counterfeit products from authentic originals. There is also the challenge of falsified medicines – the fake, unauthorised medical products that make their way into the market.

Pharmaceutical 79

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 79

Pharmaceutical Technology

FEBRUARY 15, 2023

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised.

Pharma 52

Pharma Pharmaceutical Manufacturing Medicine 52